Human term placenta as source of stem cells for regenerative medicine.

Ornella Parolini, AR Silini

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Abstract

A goal of regenerative medicine is to repair and regenerate damaged cells, tissues, and organs and ultimately restore function. Regeneration can be obtained by cell replacement or by stimulating the body’s own repair mechanisms. It requires a favorable microenvironment so that regenerative signals can stimulate resident stem/stromal cells. Regeneration is only possible after resolution of injury-induced inflammation. Immune response may be aggravated in degenerative, inflammation-based diseases. In this mini-review we discuss how cells isolated from the amniotic membrane of human term placentas and their derivatives, such as conditioned cell culture medium, can help resolve many diseases characterized by altered immune response by acting on different inflammatory mediators. Amniotic cells and derivatives have a wide spectrum of immunomodulatory properties that help trigger tissue regeneration. They can promote resolution of injury-related inflammation by reducing pro-inflammatory signals and favoring anti-inflammatory immune components. The multifaceted, immunomodulatory properties of amniotic membrane-derived cells and derivatives make them attractive for a variety of applications, especially in diseases with an exacerbated immune response, such as degenerative, inflammatory- based diseases.
Lingua originaleEnglish
pagine (da-a)147-150
Numero di pagine4
RivistaTHE EUROBIOTECH JOURNAL
Stato di pubblicazionePubblicato - 2017

Keywords

  • regenerative medicine, immunomodulation, paracrine, human term placenta, amniotic membrane, mesenchymal stromal/stem cells

Fingerprint

Entra nei temi di ricerca di 'Human term placenta as source of stem cells for regenerative medicine.'. Insieme formano una fingerprint unica.

Cita questo